Clinical Translation & Commercialisation Medtech - Information Session Round 2

MTPConnect is delivering the MRFF-funded $19.75 million Clinical Translation and Commercialisation Medtech (CTCM) program to support the development of home-grown medical devices. The program has opened its second and final funding round calling for applications from Australian small to medium-sized enterprises (SMEs) developing medical device projects for human use, the purpose of which is to diagnose, prevent, monitor, treat or alleviate a disease or injury, or modify or monitor anatomy or physiological functions of the body. Funding is offered between $250,000 - $1,500,000, for a maximum of 24 months and applicants will be required to provide a cash co-contribution to be eligible. Applications close on 7 October 2022. This episode takes you to the CTCM Information Session held in Brisbane in August and is a useful resource for applicants. You will hear from MTPConnect's Dr Duncan Macinnis, and the CTCM partners - MTAA's Stuart Anderson, MDPP's Dr Andrew Milligan and Cicada Innovation's Hebbat Mahny - on tips to consider when preparing an application.